The IQVIA Institute for Human Data Science

Evidence-based insights for healthcare

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Subscribe to the IQVIA Institute
Be among the first to hear about research and activities

Registration deadline is noon on Thursday, July 11

Advancing Evidence with Large Datasets in High-Impact Health Research

July 18-19, 2024
Boston University

In collaboration with Boston University Questrom School of Business and Boston University School of Public Health

Pathway to Success in Cancer Treatment: Achieving Radioligand Capacity and Readiness in Europe

Watch this multi-stakeholder public working session held in the European Parliament, Brussels, on achieving healthcare system readiness and capacity for radioligand therapy in Europe.

WEBINAR

Global Trends in R&D 2024 Webinar

This webinar discussion looks at current trends in R&D funding, clinical trials, innovation, and other topics related to R&D activity.

Video
Pathway to Success in Cancer Treatment: Achieving Healthcare System Readiness and Capacity for Radioligand Therapy

View all of the IQVIA Institute's Upcoming and On-Demand Events

The Global Use of Medicines

Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.

Global Trends in R&D

Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.

The Use of Medicines in the U.S.

Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.

Global Oncology Trends

Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.

Outlook for 2024: 7 Key Indicators of Progress in the Life Sciences Sector

IQVIA Institute Executive Director Murray Aitken shares what the “good news” for the life sciences sector might be in 2024 through this blog - Outlook for 2024: 7 Indicators of Progress in the Life Sciences Sector. Read about biotech, M&A activity, gene therapies, transformative drugs, AI, legislation and disruptors.

Drug Shortages in the U.S. 2023

Video discussion between Michael Kleinrock, IQVIA Institute, and Craig Burton, Association for Accessible Medicines, on key findings in the IQVIA Institute’s report on Drug Shortages in the U.S. 2023.

Follow us on Twitter
Learn more about how the IQVIA Institute contributes to the advancement of human health.
Contact Us